Oncology Clinical Trials in Aurora, CO
As of September 2026, 202 paid clinical trials are recruiting for Oncology in Aurora, Colorado. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Newly added in Aurora
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
Targeting Immune Modulation in High Grade Serous Carcinoma: Combined Effects of Chemotherapy and Atorvastatin
Effects of Risk Presentation Format and Frequently Asked Questions on Breast Cancer Risk Skepticism
205 clinical trials for Oncology
·Clear filters·Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma
Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
A Phase 1/1b Study of IAM1363 in HER2 Cancers
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)
FOG-001 in Locally Advanced or Metastatic Solid Tumors
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Combination With Intravenously Infused Obinutuzumab or Oral Acalabrutinib for Previously Untreated Chronic Lymphocytic Leukemia (CLL)
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
A Study of T-Cell Receptor Engineered Donor T Cells in Subjects Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
Top Research Study Locations in Aurora
Researchers run research studies in Aurora, CO at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Children's Hospital Colorado | Diffuse Intrinsic Pontine Glioma, High Grade Glioma, Acute Myeloid Leukemia | 166 |
| University of Colorado Anschutz Medical Campus | Obesity, Cannabis Use Disorder, Parkinson Disease | 104 |
| University of Colorado | Parkinson Disease, Acute Myeloid Leukemia, Barrett Esophagus | 84 |
| University of Colorado Hospital | Acute Kidney Injury, Carcinoma, Non-Small-Cell Lung, Lung Cancer | 57 |
| UCHealth University of Colorado Hospital | Anatomic Stage II Breast Cancer AJCC v8, Muscle Invasive Bladder Urothelial Carcinoma, Stage IV Colorectal Cancer AJCC v8 | 51 |
| Rocky Mountain Regional VA Medical Center, Aurora, CO | Aging, Chronic Pain, Fall Risk | 34 |
| University of Colorado Cancer Center | Breast Cancer, Advanced Solid Tumor, Melanoma | 34 |
| University of Colorado Denver | Depression, Anxiety, Diabetes, Retinopathy | 31 |
| University of Colorado Anschutz | Acanthamoeba Keratitis, Adiposity, Alcohol Use Disorder | 24 |
| Childrens Hospital Colorado | Hypochondroplasia, Adolescent Obesity, Anger | 15 |
| Children's Hospital of Colorado | Cystic Fibrosis, Muscular Atrophy, Spinal, Abnormal Glucose Tolerance | 14 |
| GSK Investigational Site | Gastrointestinal Neoplasms, Asthma, Bronchiectasis | 13 |
| Rocky Mountain Regional VA Medical Center | Hypertension, Melanoma, Acute Lymphoblastic Leukemia | 13 |
| University of Colorado - Anschutz Medical Campus | Aging, Hypertension, Interstitial Lung Disease | 11 |
| Rocky Mountain Cancer Centers | B-cell Lymphoma, Breast Cancer, Chronic Lymphocytic Leukemia | 10 |
| Rocky Mountain Cancer Centers-Aurora | Lung Non-Small Cell Carcinoma, Stage IIIB Lung Cancer AJCC v8, Acral Lentiginous Melanoma | 8 |
| University of Colorado School of Medicine | Cervical Cancer, Choline Deficiency, Diffuse Large B Cell Lymphoma (DLBCL) | 7 |
| University of Colorado, Denver | Arrhythmogenic Right Ventricular Cardiomyopathy, Arteriovenous Malformations, Cannabis Smoking | 6 |
| Barbara Davis Center | Type 1 Diabetes, Type 1 Diabetes (T1D), Diabetes Mellitus, Type 1 Diabetes | 6 |
| University of Colorado, Anschutz Medical Campus | Advanced Melanoma, Amputation, Bone Anchored Devices | 6 |
| Childrens Hospital of Colorado | B-ALL, Complex Congenital Heart Defect, Dysfunctional RVOT Conduit | 5 |
| Colorado Children's Hospital | Anesthesia, Caregiver Stress, Children | 5 |
| Rocky Mountain Cancer Centers, LLP | Colorectal Neoplasms, Advanced/Metastatic Urothelial Cancer, Colonic Diseases | 5 |
| UCHealth | Harm Reduction, Medication Abuse, Aging | 5 |
| Barbara Davis Center for Diabetes | Type 1 Diabetes, Type 1 Diabetes (T1D), Type 1 Diabetes Mellitus | 4 |
Active & Upcoming Studies in Aurora (2026)
Recruiting trials in Aurora grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (286 active studies)
- Trial to Evaluate an Educational Video Series for Women in Breast Cancer Treatment · University of Colorado, Denver
- Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma · Phase 2 · University of Colorado, Denver
Diabetes & metabolic (81 active studies)
Neurology & pain (60 active studies)
- Personalizing Veteran Pain Care: Adapting Coaching Interventions to Support Maintenance of Self-Care · Phase 1 · VA Office of Research and Development
- COMparison Between Anakinra and Tocilizumab in NORSE - "COMBAT-NORSE" · Phase 3 · Yale University
Cardiovascular (60 active studies)
- Pharmacist-Assisted Titration of Rx to Implement Optimal Medical Therapy for Heart Failure · VA Office of Research and Development
- A Study to Test How Well BAY 3670549 Works and How Safe it is in Patients With Atrial Fibrillation · Phase 2 · Bayer
Pediatric (29 active studies)
- Oral Antibiotic Pharmacokinetics in Young Infants · Phase 4 · University of Colorado, Denver
- A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction · Phase 3 · Bayer
Mental health & behavior (20 active studies)
- Digitally Enhanced Cognitive-Behavioral Therapy · Colorado State University
- Brexanolone Lifting Outcomes Of Moms · Phase 3 · Lipocine Inc.
HIV / STI (14 active studies)
- A Study to Evaluate the Safety and Antiviral Activity of Two Human Monoclonal Antibodies (VRC07-523LS and PGT121.414.LS) During Analytic Treatment Interruption in Participants Living With HIV Who Initiated ART During Acute/Early HIV-1 Infection · Phase 1 · National Institute of Allergy and Infectious Diseases (NIAID)
- Liver Transplantation From Donors With HIV: Impact on Opportunistic Infections, Cancer, and Long-Term Outcomes (Expanding HOPE Liver) · Johns Hopkins University
Vaccines (8 active studies)
Eye & vision (3 active studies)
- A Study to Assess Adverse Events and Effectiveness of Gel Stent (XEN63) Implantation Using Ab Interno and Ab Externo Approaches in Adult Participants With Glaucoma · Phase 3 · AbbVie
- A Phase 1/2, First-in-Human Dose Escalation/Expansion Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of a Subretinal Injection of SB-007 in Subjects With Stargardt Disease (STGD1) · Phase 1, Phase 2 · Splice Bio
Common conditions studied in Aurora
- Breast Cancer (17 active studies)
- Obesity (16 active studies)
- Colorectal Cancer (13 active studies)
- Heart Failure (13 active studies)
- Type 1 Diabetes (11 active studies)
- Melanoma (10 active studies)
Leading research sponsors in Aurora
- University of Colorado, Denver
- VA Office of Research and Development
- National Cancer Institute (NCI)
- Children's Oncology Group
- Merck Sharp & Dohme LLC
Frequently asked questions
How many paid clinical trials are currently recruiting in Aurora?
There are approximately 1,053 recruiting clinical trials in Aurora, Colorado listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Aurora pay participants?
Most recruiting trials in Aurora compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Aurora?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Aurora?
The most common conditions under active study in Aurora include Breast Cancer (17), Obesity (16), Colorectal Cancer (13), Heart Failure (13), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Aurora?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Aurora on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Aurora?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Aurora?
Recruiting research sites in Aurora include Children's Hospital Colorado, University of Colorado Anschutz Medical Campus, University of Colorado, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Aurora right now?
The largest active categories in Aurora are Cancer & tumors (286), Diabetes & metabolic (81), Neurology & pain (60). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.